These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29064732)

  • 61. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.
    Calcedo R; Vandenberghe LH; Gao G; Lin J; Wilson JM
    J Infect Dis; 2009 Feb; 199(3):381-90. PubMed ID: 19133809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areas.
    Kofoed RH; Dibia CL; Noseworthy K; Xhima K; Vacaresse N; Hynynen K; Aubert I
    J Control Release; 2022 Nov; 351():667-680. PubMed ID: 36179767
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.
    Corden A; Handelman B; Yin H; Cotrim A; Alevizos I; Chiorini JA
    Gene Ther; 2017 Apr; 24(4):241-244. PubMed ID: 28150697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Generic Method for Fast and Sensitive Detection of Adeno-Associated Viruses Using Modified AAV Receptor Recombinant Proteins.
    Cui M; Lu Y; Tang C; Zhang R; Wang J; Si Y; Cheng S; Ding W
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31684125
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of Adeno-Associated Virus 3 Capsid Binding and Neutralizing Antibodies in Healthy and Hemophilia B Individuals from India.
    Daniel HD; Kumar S; Kannangai R; Lakshmi KM; Agbandje-Mckenna M; Coleman K; Srivastava A; Srivastava A; Abraham AM
    Hum Gene Ther; 2021 May; 32(9-10):451-457. PubMed ID: 33207962
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: implications for gene therapy.
    van der Marel S; Comijn EM; Verspaget HW; van Deventer S; van den Brink GR; Petry H; Hommes DW; Ferreira V
    Inflamm Bowel Dis; 2011 Dec; 17(12):2436-42. PubMed ID: 21370319
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Humoral and cellular capsid-specific immune responses to adeno-associated virus type 1 in randomized healthy donors.
    Veron P; Leborgne C; Monteilhet V; Boutin S; Martin S; Moullier P; Masurier C
    J Immunol; 2012 Jun; 188(12):6418-24. PubMed ID: 22593612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
    Wu Z; Asokan A; Samulski RJ
    Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.
    Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM
    J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions.
    Weber T
    Front Immunol; 2021; 12():658399. PubMed ID: 33815421
    [TBL] [Abstract][Full Text] [Related]  

  • 71. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
    Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA.
    Gray AL; O'Leary C; Liao A; Agúndez L; Youshani AS; Gleitz HF; Parker H; Taylor JT; Danos O; Hocquemiller M; Palomar N; Linden RM; Henckaerts E; Holley RJ; Bigger BW
    Hum Gene Ther; 2019 Sep; 30(9):1052-1066. PubMed ID: 31020862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy.
    Schulz M; Levy DI; Petropoulos CJ; Bashirians G; Winburn I; Mahn M; Somanathan S; Cheng SH; Byrne BJ
    Mol Ther; 2023 Mar; 31(3):616-630. PubMed ID: 36635967
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vector serotype screening for use in ovine perinatal lung gene therapy.
    McClain LE; Davey MG; Zoltick PW; Limberis MP; Flake AW; Peranteau WH
    J Pediatr Surg; 2016 Jun; 51(6):879-84. PubMed ID: 27032612
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells.
    Teschendorf C; Emons B; Muzyczka N; Graeven U; Schmiegel W
    Anticancer Res; 2010 Jun; 30(6):1931-5. PubMed ID: 20651336
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
    Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes.
    Cottard V; Valvason C; Falgarone G; Lutomski D; Boissier MC; Bessis N
    J Clin Immunol; 2004 Mar; 24(2):162-9. PubMed ID: 15024183
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors.
    Du L; Kido M; Lee DV; Rabinowitz JE; Samulski RJ; Jamieson SW; Weitzman MD; Thistlethwaite PA
    Mol Ther; 2004 Sep; 10(3):604-8. PubMed ID: 15336660
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.
    Tseng YS; Vliet KV; Rao L; McKenna R; Byrne BJ; Asokan A; Agbandje-McKenna M
    J Virol Methods; 2016 Oct; 236():105-110. PubMed ID: 27424005
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
    Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
    Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.